Properties of metastasizing and nonmetastasizing human melanoma cells
- PMID: 7597284
- DOI: 10.1007/978-3-642-78771-3_8
Properties of metastasizing and nonmetastasizing human melanoma cells
Abstract
Dissemination of tumor cells includes several steps, such as: (a) detachment of tumor cells from the primary tumor, (b) traversement of the basement membrane, and (c) migration into the extracellular matrix. In these processes, at least two important categories of proteins are involved: proteases and adhesion molecules. In this contribution we describe the expression and function of components of the plasminogen activator (PA) system (proteases) and of integrins (cell-matrix adhesion molecules) in a panel of four human melanoma cell lines with different invasive and metastatic capacity. Regarding the components of the PA system, we found differences in expression of urokinase-type PA (uPA) and type 1 and 2 PA inhibitors (PAI-1 and -2) between metastasizing and nonmetastasizing cell lines. Both components were exclusively expressed in the highly invasive and metastatic cell lines. Interestingly, studies on the expression of PA components in fresh human melanocytic lesions, showed expression of these components exclusively in advanced primary melanomas and melanoma metastases. Regarding integrin expression we found elevated levels of VLA-2 and VLA-6 in the highly invasive and metastatic cell lines compared with normal cultured melanocytes and nonmetastatic melanoma cell lines. In addition, increased adhesion of the highly metastatic cell lines to laminin (LM) and collagen (COLL) was observed. Furthermore, reduced adhesion of normal melanocytes and nonmetastatic melanoma cells to LM and CO was mainly due to the fact that the integrins involved in adhesion to these matrix components were present in an inactive state. Finally, differences were observed in expression of integrins involved in adhesion to fibronectin.
Similar articles
-
Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and in non-metastatic and highly metastatic human melanoma cells.Int J Cancer. 1993 May 8;54(2):315-21. doi: 10.1002/ijc.2910540225. Int J Cancer. 1993. PMID: 8387465
-
The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis.Cancer Res. 1999 Mar 15;59(6):1327-36. Cancer Res. 1999. PMID: 10096567
-
Different roles for plasminogen activators and metalloproteinases in melanoma metastasis.Curr Top Microbiol Immunol. 1996;213 ( Pt 1):65-80. doi: 10.1007/978-3-642-61107-0_5. Curr Top Microbiol Immunol. 1996. PMID: 8814995 Review.
-
Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.Am J Pathol. 1994 Jan;144(1):70-81. Am J Pathol. 1994. PMID: 8291613 Free PMC article.
-
The plasminogen activation system in melanoma cell lines and in melanocytic lesions.Melanoma Res. 1996 Apr;6(2):79-88. doi: 10.1097/00008390-199604000-00001. Melanoma Res. 1996. PMID: 8791264 Review.
Cited by
-
Chromosome 7 aneusomy. A marker for metastatic melanoma? Expression of the epidermal growth factor receptor gene and chromosome 7 aneusomy in nevi, primary malignant melanomas and metastases.Neoplasia. 2001 May-Jun;3(3):245-54. doi: 10.1038/sj.neo/7900156. Neoplasia. 2001. PMID: 11494118 Free PMC article.
-
SERPINE1 expression discriminates site-specific metastasis in human melanoma.Exp Dermatol. 2012 Jul;21(7):551-4. doi: 10.1111/j.1600-0625.2012.01523.x. Exp Dermatol. 2012. PMID: 22716255 Free PMC article.
-
Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential.Br J Cancer. 1997;76(5):561-70. doi: 10.1038/bjc.1997.427. Br J Cancer. 1997. PMID: 9303353 Free PMC article.
-
The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells.BMC Cancer. 2008 Jan 16;8:9. doi: 10.1186/1471-2407-8-9. BMC Cancer. 2008. PMID: 18199328 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous